Anthony L. Schwartz

National Institutes of Health — United States

Immunology and Microbiology · Life Sciences

18h-index1.0kcitations54works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(18), Phagocytosis and Immune Regulation(14), Immunotherapy and Immune Responses(9), Immune cells in cancer(9), T-cell and B-cell Immunology(8)

Publications52 total

Data from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
2023Open Access
Table S4 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
2023Open Access
Table S4 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
2023Open Access
Supplementary methods, tables, figures S1-S7 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
2023Open Access
Data from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
2023Open Access
Table S3 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
2023Open Access
Table S3 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
2023Open Access
Supplementary methods, tables, figures S1-S7 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
2023Open Access
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation
Cancer Immunology Immunotherapy·2019· 59 citedOpen Access
Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors
Frontiers in Oncology·2019· 31 citedOpen Access
Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
Cancer Immunology Research·2019· 99 cited
Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy
Breast Cancer Research and Treatment·2018· 54 cited
CTLA4 and CD47 combinational therapy to extend survival in melanoma.
Journal of Clinical Oncology·2017· 1 cited
Abstract 3054: CD47 signaling regulates a DNA damage response pathway by suppressing the expression of Schlafen-11 (SLFN11)
Cancer Research·2016
TLR signaling inhibitor, phenylmethimazole, in combination with tamoxifen inhibits human breast cancer cell viability and migration
Oncotarget·2016· 16 citedOpen Access
CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation
Journal of Biological Chemistry·2015· 75 citedOpen Access
Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice
Current Molecular Medicine·2015· 7 cited
CD47-Dependent Regulation of H2S Biosynthesis and Signaling in T Cells
Methods in enzymology on CD-ROM/Methods in enzymology·2015· 22 citedOpen Access
Toll-Like Receptors as Novel Therapeutic Targets for the Treatment of Pancreatic Cancer
InTech eBooks·2012· 1 citedOpen Access
Phenylmethimazole inhibits production of proinflammatory mediators and is protective in an experimental model of endotoxic shock*
Critical Care Medicine·2011· 9 cited
page 1 of 3Next →

Frequent Co-authors

David D. Roberts(15), Richard K. Gershon(10), Pulak Ranjan Nath(10), Ajeet Mandal(8), Margaret C. Cam(8), Dipasmita Pal-Nath(7), Philip W. Askenase(6), Ramiro Malgor(5), Kelly D. McCall(5), Leonard D. Kohn(4), Sandra L. Sutton(4), David R. Soto‐Pantoja(3), Lisa A. Ridnour(3), Eric Dickerson(3), Sukhbir Kaur(3), Robert O. Jacoby(3), P. N. Bhatt(3), Thomas W. Miller(2), John M. Sipes(2), Norikazu Harii(2)